Fund Tracker India by Ishaan Dungarwal
Guide

HDFC Pharma and Healthcare Fund

Holdings for Oct 2026, changes against Sep 2026, from HDFC Mutual Fund's monthly file.

HDFC Pharma and Healthcare Fund portfolio holdings, Oct 2026: 38 stocks, ₹3,621 cr in listed equity, from HDFC Mutual Fund's monthly disclosure; changes by share count against Sep 2026.

Fund managers: Nikhil Mathur; Gopal Agrawal; Bhagyesh Kagalkar

Benchmark: BSE Healthcare Index (TRI) · Riskometer: Very High · SEBI category, as filed: Sectoral Fund · Allotted 4 Oct 2023

Source: AMFI scheme summary document

NAV

HDFC Pharma and Healthcare Fund - Direct Plan - Growth Option

Source: AMFI

₹23.675020 Nov 2026
AUM

average for July - September 2026, all plans.

Source: AMFI

₹3,128 crJuly - September 2026
Expense ratio

The scheme's yearly running cost as a % of its assets, taken out of the NAV a little each day. A regular plan costs more: it pays a distributor's commission.

Category median: direct 1.23 %, regular 2.40 % (174 schemes) · Regular costs ₹1,010 more a year per ₹1 lakh

Of this, the base expense ratio, the part SEBI caps: direct 0.75 %, regular 1.63 %. The rest is brokerage, transaction costs and statutory levies such as GST and STT, as AMFI's file lists them.

A year, as of 19 Nov 2026. Source: AMFI · Glossary: TER

Direct 1.08 %Regular 2.09 %
Equity held

38 stocks, Oct 2026.

Source: HDFC Mutual Fund monthly portfolio

₹3,621 cr38 stocks · Oct 2026
Equity, % of fund

As the AMC's file prints % of NAV. The top 10 stocks together: 51.7%.

98.8%top 10 stocks 51.7%

This month: Oct 2026

compared with Sep 2026 · by share count

Equity held vs NAV

The teal line is the scheme's equity at month end, from its portfolio file; the faint line is the plan's NAV. Equity held moves with prices and with money in or out, the NAV with prices only.

last 12 months to Oct 2026
Nov 2025: equity held ₹1,978 cr, 31 stocks, NAV ₹18.00Dec 2025: equity held ₹1,940 cr, 30 stocks, NAV ₹17.70Jan 2026: equity held ₹1,826 cr, 29 stocks, NAV ₹16.96Feb 2026: equity held ₹1,995 cr, 29 stocks, NAV ₹18.29Mar 2026: equity held ₹1,947 cr, 29 stocks, NAV ₹17.49Apr 2026: equity held ₹2,100 cr, 31 stocks, NAV ₹18.81May 2026: equity held ₹2,332 cr, 32 stocks, NAV ₹19.93Jun 2026: equity held ₹2,539 cr, 35 stocks, NAV ₹21.08Jul 2026: equity held ₹2,925 cr, 37 stocks, NAV ₹21.79Aug 2026: equity held ₹3,258 cr, 39 stocks, NAV ₹22.62Sep 2026: equity held ₹3,388 cr, 38 stocks, NAV ₹21.94Oct 2026: equity held ₹3,621 cr, 38 stocks, NAV ₹21.95
% change and month by month (tables)
% change to Oct 2026
OverSinceEquity heldNAV
3 monthsJul 2026▲ +23.8%▲ +0.7%
6 monthsApr 2026▲ +72.4%▲ +16.7%
12 monthsOct 2025▲ +87.3%▲ +23.8%
MonthEquity heldStocksNAV at month end
Nov 2025₹1,978 cr31₹18.0020
Dec 2025₹1,940 cr30₹17.7040
Jan 2026₹1,826 cr29₹16.9580
Feb 2026₹1,995 cr29₹18.2910
Mar 2026₹1,947 cr29₹17.4940
Apr 2026₹2,100 cr31₹18.8140
May 2026₹2,332 cr32₹19.9280
Jun 2026₹2,539 cr35₹21.0790
Jul 2026₹2,925 cr37₹21.7900
Aug 2026₹3,258 cr39₹22.6180
Sep 2026₹3,388 cr38₹21.9440
Oct 2026₹3,621 cr38₹21.9520
Oct 2026 · Sources: AMC monthly portfolio (SEBI disclosure); AMFI NAV files · How to read

Moves, Oct 2026

How many stocks the scheme bought into, added to, cut or sold out of this month, by share count, so a price move alone never counts.

vs Sep 2026
  • New1
  • Added11
  • Trimmed2
  • Exited1
Stocks, by share count · Source: HDFC Mutual Fund monthly portfolios Report a wrong number

Asset mix, Oct 2026

How much of the fund sits in listed shares; the rest is foreign shares, debt, money market, cash and other assets.

% of fund
  1. Listed equity
    98.8%
  2. Rest, not itemised
    1.2%
Source: HDFC Mutual Fund monthly portfolio

Rest = foreign shares, debt, money market, cash, REIT/InvIT units and other assets.

Sectors and top 10, Oct 2026

Sector mix, Oct 2026

How the scheme's equity is spread across sectors at month end.

% of equity held
Source: HDFC Mutual Fund monthly portfolio; AMFI

AMFI's 22 sectors; one sector per stock, from the fund houses' industry labels.

Report a wrong number

Large, mid and small cap, Oct 2026

How the scheme's equity splits across large, mid and small companies, on AMFI's list.

% of equity held
  1. Small Cap
    32.2%
  2. Mid Cap
    32.0%
  3. Large Cap
    30.1%
  4. Not in AMFI's list
    5.7%
Source: HDFC Mutual Fund monthly portfolio; AMFI

AMFI's list of Jun 2026.

Report a wrong number

Top 10 holdings

Its ten largest stocks, each as a share of the fund.

% of fund · 51.7% together
  1. 9.44%
  2. 7.74%
  3. 6.66%
  4. 5.19%
  5. 4.75%
  6. 4.06%
  7. 3.70%
  8. 3.44%
  9. 3.37%
  10. 3.35%
Source: HDFC Mutual Fund monthly portfolio

As the AMC's file prints % of NAV.

Sector weight change

Each sector's share of the fund now less a month before. It moves with prices as well as trades.

vs Sep 2026 · points of equity held
  1. +0.1 pts
  2. −0.1 pts
Source: HDFC Mutual Fund monthly portfolios

Largest moves first, up to 10.

Changes, Oct 2026 vs Sep 2026

Every stock whose share count changed: new, added, trimmed, exited.

15 stocks · by share count
StockChangeShares beforeShares nowDifferenceChange %Value of changeValue now
PARASHLTH New—11.57 lakh+11.57 lakh—+₹85.7 cr₹85.7 cr
DRREDDY Added9.05 lakh18.05 lakh+9.00 lakh+99.5%+₹122 cr₹244 cr
APOLLOHOSP Added1.58 lakh2.25 lakh+67,000+42.4%+₹56.6 cr₹190 cr
ALKEM Added3.15 lakh3.40 lakh+25,368+8.1%+₹13.0 cr₹174 cr
MAXHEALTH Added13.60 lakh14.67 lakh+1.07 lakh+7.9%+₹9.2 cr₹126 cr
ASTERDM Added17.86 lakh18.11 lakh+25,200+1.4%+₹1.7 cr₹123 cr
NEULANDLAB Added53,16455,014+1,850+3.5%+₹3.6 cr₹108 cr
SHILPAMED Added10.81 lakh11.21 lakh+40,000+3.7%+₹3.8 cr₹107 cr
RUBICON Added5.44 lakh6.13 lakh+68,991+12.7%+₹11.1 cr₹98.8 cr
MEDANTA Added6.98 lakh7.27 lakh+28,657+4.1%+₹3.6 cr₹92.3 cr
SAILIFE Added3.62 lakh4.09 lakh+47,405+13.1%+₹7.4 cr₹63.8 cr
JLHL Added23.24 lakh23.65 lakh+41,027+1.8%+₹1.1 cr₹60.8 cr
IPCALAB Trimmed5.42 lakh3.67 lakh−1.75 lakh−32.3%−₹33.8 cr₹70.7 cr
GLAND Trimmed2.15 lakh1.25 lakh−90,370−42.0%−₹28.0 cr₹38.6 cr
COHANCE Exited2.50 lakh—−2.50 lakh—−₹11.1 cr₹11.1 cr
Source: HDFC Mutual Fund monthly portfolios

Value of change = the difference in shares × this month's price in the AMC's file. Value now = the whole holding's market value in that file (an exit: last month's).

How to read

Report a wrong number

Full portfolio, Oct 2026 (38 stocks)

Every listed stock in the month's file, largest first.

largest first, by value
Company Sector
DIVISLABDivi's Laboratories Limited Healthcare3.54 lakh₹346 cr9.44%
SUNPHARMASun Pharmaceutical Industries Limited Healthcare15.95 lakh₹284 cr7.74%
DRREDDYDr. Reddy's Laboratories Limited Healthcare18.05 lakh₹244 cr6.66%
APOLLOHOSPApollo Hospitals Enterprise Limited Healthcare2.25 lakh₹190 cr5.19%
ALKEMAlkem Laboratories Limited Healthcare3.40 lakh₹174 cr4.75%
CIPLACipla Limited Healthcare10.80 lakh₹149 cr4.06%
ACUTAASAcutaas Chemicals Limited Healthcare3.39 lakh₹136 cr3.70%
MAXHEALTHMax Healthcare Institute Limited Healthcare14.67 lakh₹126 cr3.44%
ASTERDMAster DM Quality Care Limited Healthcare18.11 lakh₹123 cr3.37%
LUPINLupin Limited Healthcare6.12 lakh₹123 cr3.35%
TORNTPHARMTorrent Pharmaceuticals Limited Healthcare2.66 lakh₹123 cr3.35%
NEULANDLABNeuland Laboratories Limited Healthcare55,014₹108 cr2.96%
SHILPAMEDShilpa Medicare Ltd. Healthcare11.21 lakh₹107 cr2.92%
ANTHEMAnthem Biosciences Limited Healthcare12.92 lakh₹107 cr2.92%
RUBICONRubicon Research Limited Healthcare6.13 lakh₹98.8 cr2.69%
MEDANTAGlobal Health Limited Healthcare7.27 lakh₹92.3 cr2.52%
PARASHLTHParas Healthcare Limited Healthcare11.57 lakh₹85.7 cr2.34%
GLENMARKGlenmark Pharmaceuticals Limited Healthcare3.13 lakh₹71.9 cr1.96%
IPCALABIPCA Laboratories Limited Healthcare3.67 lakh₹70.7 cr1.93%
VIJAYAVijaya Diagnostic Centre Limited Healthcare4.88 lakh₹70.6 cr1.92%
KIMSKrishna Institute Of Medical Sciences Limited Healthcare9.85 lakh₹69.1 cr1.89%
MOLBIOMolbio Diagnostics Limited Healthcare5.38 lakh₹68.5 cr1.87%
ZYDUSLIFEZydus Lifesciences Limited Healthcare5.49 lakh₹68.4 cr1.86%
SAILIFESai Life Sciences Limited Healthcare4.09 lakh₹63.8 cr1.74%
JLHLJupiter Life Line Hospitals Limited Healthcare23.65 lakh₹60.8 cr1.66%
METROPOLISMetropolis Healthcare Limited Healthcare10.81 lakh₹59.0 cr1.61%
WOCKPHARMAWockhardt Limited Healthcare2.83 lakh₹53.9 cr1.47%
SYMBIOTECSymbiotec Pharmalab Limited Healthcare4.05 lakh₹50.5 cr1.38%
BIOCONBiocon Limited Healthcare13.90 lakh₹48.9 cr1.33%
GLANDGland Pharma Limited Healthcare1.25 lakh₹38.6 cr1.05%
CORONACorona Remedies Limited Healthcare1.73 lakh₹37.3 cr1.02%
THYROCAREThyrocare Technologies Limited Healthcare7.19 lakh₹32.8 cr0.90%
ENTEROEntero Healthcare Solutions Ltd Consumer Services2.07 lakh₹32.6 cr0.89%
ERISEris Lifesciences Limited Healthcare2.71 lakh₹31.4 cr0.86%
JUBLPHARMAJubilant Pharmova Limited Healthcare3.18 lakh₹29.3 cr0.80%
BAJAJHCAREBajaj Healthcare Limited Healthcare5.69 lakh₹17.4 cr0.48%
EVONILENovartis India Limited Healthcare1.01 lakh₹17.0 cr0.46%
LAXMIDENTLLaxmi Dental Limited Healthcare6.44 lakh₹11.4 cr0.31%
Show all 38 stocksShow the first 15

Equity rows as disclosed, Oct 2026. Source: HDFC Mutual Fund monthly portfolio. Report a wrong number

Large, mid and small caps, % of net assets, last 12 months

AMFI list in force each month
MonthLargeMidSmallNot in AMFI's listAMFI list
Oct 202629.8%31.6%31.9%5.6%Jun 2026
Sep 202629.2%30.1%34.2%3.4%Jun 2026
Aug 202627.9%33.2%34.4%3.0%Jun 2026
Jul 202627.3%37.3%34.9%0.0%Jun 2026
Jun 202628.9%29.2%39.1%0.0%Dec 2025
May 202627.4%34.2%37.1%0.0%Dec 2025
Apr 202628.9%34.5%33.9%0.0%Dec 2025
Mar 202626.7%37.0%34.8%0.0%Dec 2025
Feb 202626.9%37.3%34.0%0.0%Dec 2025
Jan 202628.6%36.6%32.1%0.0%Dec 2025
Dec 202537.7%24.1%29.9%6.1%Jun 2025
Nov 202538.8%23.1%31.6%4.9%Jun 2025
Sources: HDFC Mutual Fund monthly portfolios; AMFI. How to read

Equity holdings' % of net assets each month, by AMFI's cap list in force that month.

Portfolio turnover, from holdings

equity only · month-end snapshots
Turnover, 12 months32.0%Oct 2025 to Oct 2026 · bought ₹2,027 cr, sold ₹773 cr
MonthBoughtSoldTurnover
Oct 2026₹319 cr₹72.8 cr2.1%
Sep 2026₹347 cr₹106 cr3.2%
Aug 2026₹235 cr₹6.9 cr0.2%
Jul 2026₹310 cr₹0.00 cr0.0%
Jun 2026₹154 cr₹83.4 cr3.4%
May 2026₹214 cr₹106 cr4.8%
Apr 2026₹129 cr₹125 cr6.2%
Mar 2026₹48.7 cr₹11.0 cr0.6%
Feb 2026₹69.1 cr₹39.3 cr2.1%
Jan 2026₹46.4 cr₹80.0 cr2.5%
Dec 2025₹90.8 cr₹94.1 cr4.6%
Nov 2025₹65.3 cr₹48.3 cr2.5%
Source: HDFC Mutual Fund monthly portfolios. How to read

The lower of bought and sold over the average equity value, from month-end holdings; it can differ from the fund house's own figure.

Returns next to the benchmark

What the plan's NAV did over each period, as AMFI publishes it.

as of 19 Nov 2026 · as published by AMFI
PeriodDirect planRegular planBenchmark, as published by AMFI BSE Healthcare TRI
1 year+31.59 %+30.13 %+19.11 %
3 years+30.55 %+29.02 %+22.11 %
Since launch+31.58 %+30.03 %+23.19 %

Past performance may not be sustained in future.

Source: AMFI fund performance

As AMFI's fund performance report prints them for "HDFC Pharma and Healthcare Fund"; this site computes no benchmark figure of its own.

How to read

How it is computed: NAV to NAV

HDFC Pharma and Healthcare Fund - Direct Plan - Growth Option: these run to the newest NAV stored (20 Nov 2026) and are computed here from AMFI's NAV files; AMFI's figures above run to 19 Nov 2026, so the two differ by the days in between.

PeriodReturnFromTo
1 year+32.20 % in total 20 Nov 2025 · NAV ₹17.909020 Nov 2026 · NAV ₹23.6750
3 years+30.70 % a year, compounded 20 Nov 2023 · NAV ₹10.597020 Nov 2026 · NAV ₹23.6750
Since first NAV+31.83 % a year, compounded 4 Oct 2023 · NAV ₹9.965020 Nov 2026 · NAV ₹23.6750

Source: AMFI NAV files (plan code 152082). How to read Report a wrong number

IDCW (dividend) history

0 declarations · as of 3 Nov 2026 · Source: AMFI
AMFI lists no IDCW declared by this scheme.
Source: AMFI scheme dividends. How to read

IDCW (formerly "dividend") declared per unit of each IDCW plan, as AMFI lists it.

Rolling returns, HDFC Pharma and Healthcare Fund - Direct Plan - Growth Option

weekly NAVs · Source: AMFI
WindowLowestMedianHighestWindows above zero
1 year in total +2.39 % 3 Jan 2025 to 9 Jan 2026+24.10 % 9 May 2025 to 15 May 2026+67.76 % 27 Oct 2023 to 31 Oct 2024 100 % of 111 windows ending 11 Oct 2024 to 20 Nov 2026

Past performance may not be sustained in future.

Source: AMFI NAV files. How to read

Every 1-, 3- and 5-year window ending on a week's last NAV, lowest, middle and highest.

Volatility, a year

Standard deviation of weekly NAV changes × √52. 24 Nov 2023 to 20 Nov 2026, 156 weekly changes.

Source: AMFI

15.19 %156 weeks to 20 Nov 2026
Largest fall from a high

High 3 Jan 2025, low 28 Feb 2025; back at the high 4 Jul 2025.

Weekly NAVs since 6 Oct 2023. Measured on each week's last NAV, so a fall within a week can be deeper than shown.

Source: AMFI

−14.67 %low 28 Feb 2025

Past performance may not be sustained in future.

Next to its category: Sectoral or thematic

weekly NAVs · Source: AMFI
Rolling windowLower quarterUpper quarterAbove 6 %Above 9 %Above 12 %Above the category average
1 year+13.6 %+29.7 % 93.7 %82.0 %76.6 % 94.6 % of 111 windows
How this is counted

Same windows as the rolling returns above. A quarter of the windows returned less than the lower quarter, and a quarter more than the upper. "Above" columns give the share of windows. The category average is the average for windows ending the same week.

Market phases

PhaseDatesThis schemeCategory average
Foreign selling, 2024–2527 Sep 2024 to 28 Feb 2025 in total−9.3 %−19.2 % 148 schemes
Since March 202528 Feb 2025 to 20 Nov 2026 a year, compounded+31.2 %+15.5 % 165 schemes

The phases are the site's own split of the market since 2015, measured from month end to month end.

From each quarter end to the newest NAV

FromDatesThis schemeCategory average
From Jun 202625 Jun 2026 to 20 Nov 2026 in total+14.1 %+4.6 % 195 schemes
From Mar 202627 Mar 2026 to 20 Nov 2026 in total+33.7 %+18.0 % 195 schemes
From Dec 202526 Dec 2025 to 20 Nov 2026 in total+33.7 %+6.8 % 188 schemes
From Sep 202526 Sep 2025 to 20 Nov 2026 a year, compounded+32.3 %+8.9 % 182 schemes
From Jun 202527 Jun 2025 to 20 Nov 2026 a year, compounded+26.7 %+6.0 % 173 schemes
From Mar 202528 Mar 2025 to 20 Nov 2026 a year, compounded+25.8 %+11.8 % 169 schemes
From Dec 202427 Dec 2024 to 20 Nov 2026 a year, compounded+18.9 %+5.8 % 159 schemes
From Sep 202427 Sep 2024 to 20 Nov 2026 a year, compounded+18.9 %+1.5 % 148 schemes
From Jun 202428 Jun 2024 to 20 Nov 2026 a year, compounded+27.5 %+5.4 % 139 schemes
From Mar 202428 Mar 2024 to 20 Nov 2026 a year, compounded+27.8 %+9.8 % 133 schemes
From Dec 202329 Dec 2023 to 20 Nov 2026 a year, compounded+28.9 %+11.5 % 127 schemes
Spread of falling weeks, a year

Root mean square of the weekly falls × √52 (rising weeks count as zero).

9.3 %24 Nov 2023 to 20 Nov 2026
Up capture

Its average change in the 92 weeks the category average rose, as a share of the category's.

105.9 %92 rising weeks
Down capture

The same for the 64 weeks the category average fell.

66.5 %64 falling weeks

Past performance may not be sustained in future.

Source: AMFI NAV files.

Category average = the plain average for the other schemes in the same AMFI category with the same figure (direct growth plans, each week's last NAV). It is not an index, and the scheme's place among them is not shown. Peers are today's schemes in today's category, so a scheme that has closed is not in the average, and SEBI re-sorted the categories in 2018.

52-week high NAV

Highest and lowest of 248 daily NAVs, 20 Nov 2025 to 20 Nov 2026, HDFC Pharma and Healthcare Fund - Direct Plan - Growth Option.

Source: AMFI

₹23.675020 Nov 2026
52-week low NAV₹16.83202 Feb 2026

Calendar-year returns, HDFC Pharma and Healthcare Fund - Direct Plan - Growth Option

NAV to NAV · Source: AMFI
YearReturnFromTo
2025+2.42 % 31 Dec 2024 · NAV ₹17.286031 Dec 2025 · NAV ₹17.7040
2024+52.22 % 29 Dec 2023 · NAV ₹11.356031 Dec 2024 · NAV ₹17.2860

Past performance may not be sustained in future.

Change in the plan's NAV over each calendar year, last NAV to last NAV. Source: AMFI NAV files. How to read

Monthly SIP of ₹10,000, HDFC Pharma and Healthcare Fund - Direct Plan - Growth Option

XIRR · Source: AMFI
PeriodInstalmentsPaid inValueXIRR, a year
1 year 1 Dec 2025 to 2 Nov 202612 ₹1,20,000₹1,45,678 20 Nov 2026 · NAV ₹23.6750+44.62 %

Past performance may not be sustained in future.

Source: AMFI NAV files. How to read

₹10,000 on the first NAV of each month, valued at the newest NAV; no stamp duty, exit load or tax taken off.

Embed this card

Card for this scheme: facts with source and date

Copy this into any web page. The image carries its source, date and a link back; it is redrawn each night.

Portfolios most like this one, Oct 2026

same category, other fund houses
Most alike and most unique funds →

Overlap is the sum, over stocks both hold, of the smaller of the two weights. A measured likeness, not a suggestion to switch.

From AMFI's own files (scheme summary documents, NAV history, TER), as they stood on the day shown.

Questions about HDFC Pharma and Healthcare Fund

from the figures on this page

What are the top holdings of HDFC Pharma and Healthcare Fund?

At Oct 2026 end, HDFC Pharma and Healthcare Fund held 38 stocks (98.8% of the fund in equity). Largest: Divi's Laboratories 9.44%, Sun Pharmaceutical Industries 7.74%, Dr. Reddy's Laboratories 6.66%, Apollo Hospitals Enterprise 5.19%, Alkem Laboratories 4.75%; the top 10 make up 51.7%. Funds holding Divi's Laboratories · Funds holding Sun Pharmaceutical Industries · Funds holding Dr. Reddy's Laboratories

What portfolio changes did HDFC Pharma and Healthcare Fund make in Oct 2026?

Compared with Sep 2026, by share count: 1 new, 11 added, 2 trimmed, 1 exited. Largest by value: Paras Healthcare (new), Dr. Reddy's Laboratories (added), Apollo Hospitals Enterprise (added), Alkem Laboratories (added).

Who manages HDFC Pharma and Healthcare Fund?

AMFI's scheme summary document names Nikhil Mathur, Gopal Agrawal, Bhagyesh Kagalkar for HDFC Pharma and Healthcare Fund (HDFC Mutual Fund). Nikhil Mathur, fund manager portfolio · Gopal Agrawal, fund manager portfolio · Bhagyesh Kagalkar, fund manager portfolio

All schemes of HDFC Mutual Fund →

Mutual fund investments are subject to market risks; read all scheme related documents carefully.